User:ComparisonCato
Editor·499 edits·since 2025/12
ComparisonCato is an editor on PeptidePedia Wiki, editing since 2025 / 12.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
499Total edits
22Logged here
17Articles touched
2025/12Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Dulaglutide | 3 | 26 | 12% |
| Lixisenatide | 3 | 26 | 12% |
| Semaglutide | 2 | 41 | 5% |
| Dose escalation schedule | 1 | 33 | 3% |
| Sigma-Aldrich (Shanghai) Trading | 1 | 35 | 3% |
| Third-party testing | 1 | 39 | 3% |
| Triple agonist | 1 | 30 | 3% |
| Cold chain | 1 | 44 | 2% |
| GLP-1 receptor agonist | 1 | 43 | 2% |
| Orforglipron | 1 | 28 | 4% |
| CagriSema | 1 | 31 | 3% |
| Retatrutide | 1 | 43 | 2% |
| Peptide | 1 | 41 | 2% |
| Haemoglobin A1c | 1 | 26 | 4% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.